No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases - Data from the finnish national registry for kidney diseases

Journal of Rheumatology

Volumn 35, Issue 7, 2008, Pages 1334-1338

  Immonen, Kai ^a   Finne, Patrik ^b   Hakala, Markku ^c,d   Kautiainen, Hannu ^c   Pettersson, Tom ^b   Grönhagen Riska, Carola ^b  

^a NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Amyloidosis; Ankylosing spondylitis; Juvenile idiopathic arthritis; Renal disorder; Renal replacement therapy; Rheumatoid arthritis

Indexed keywords

ADULT; AMYLOIDOSIS; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AMYLOIDOSIS; FEMALE; FINLAND; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; REGISTRIES; RENAL DIALYSIS; RHEUMATIC DISEASES;

EID: 47349109629     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Isomäki H. Shortening of life span and causes of excess mortality in a population based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol 1995;13:149-53.
2. Myllykangas-Luosujärvi R, Aho K, Lehtinen K, Kautiainen H, Hakala M. Increased incidence of alcohol-related deaths from accidents and violence in subjects with ankylosing spondylitis. Br J Rheumatol 1998;37:688-90.
3. Braun J, Pincus T. Mortality, course of disease and prognosis with ankylosing spondylitis. Clin Exp Rheumatol 2002;20 Supph:S16-22.
4. Savolainen HA, Isomäki HA. Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol 1993;20:1201-3.
5. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993;52:174-6.
6. Suzuki A, Ohosone Y, Obana M, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 1994;21:33-6.
7. Kaipiainen-Seppänen O, Myllykangas-Luosujärvi R, Lampainen E, Ikäheimo R. Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis. Scand J Rheumatol 2000;29:232-5.
8. David J, Vouyiouka O, Ansell BM, Hall A, Woo P. Amyloidosis in chronic juvenile arthritis: a morbidity and mortality study. Clin Exp Rheumatol 1993;11:85-90.
9. Savolainen HA. Chlorambucil in severe juvenile chronic arthritis: longterm follow-up with special reference to amyloidosis. J Rheumatol 1999;26:898-903.
10. Musiej-Nowakowska E, Berkan E. Decrease of reactive amyloidosis in juvenile chronic arthritis in Polish population: a preliminary report. Clin Exp Rheumatol 2005;23 Suppl:28.
11. Immonen K, Savolainen A, Kautiainen H, Hakala M. Why can we no longer find juvenile idiopathic arthritis-associated amyloidosis in childhood or in adolescence in Finland? Scand J Rheumatol 2007;36:402-3.
12. Laiho K, Tiitinen S, Kaarela K, Helin H, Isomäki H. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 1999;18:122-3.
13. Sihvonen S, Korpela M, Mustonen J, Laippala P, Pasternack A. Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract 2004;96:107-14.
14. Kuroda T, Tanabe N, Harada T, et al. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol 2005;25:498-505.
15. Finne P, Reunanen A, Stenman S, Groop P-H, Grönhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005;14:1782-7.
16. Lachmann HJ, Goodman HJB, Gilbertson JA, et al. Natural history and outcome in systemic amyloidosis. N Engl J Med 2007;356:2361-71.
17. Mazzuchi N, Schwedt E, Fernández JM, et al. Latin American registry of dialysis and renal transplantation: 1993 annual dialysis data report. Nephrol Dial Transplant 1997;12:2521-7.
18. Bleyer AJ, Donaldson LA, McIntosh M, Adams PL. Relationship between underlying renal disease and renal transplantation outcome. Am J Kidney Dis 2001;37:1152-61.
19. van Dijk PCW, Jager KJ, de Charro F, et al. Renal replacement therapy in Europe: the results of a collaborative effort by ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001;16:1120-9.
20. Kyle RA, Linos A, Beard CM, et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 1992;79:1817-22.
21. Berthoux F, Jones E, Gellert R, et al. Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and national registries. Nephrol Dial Transplant 1999;14:2332-42.
22. Finnish Registry for Kidney Disease. Annual Report 2004. Available from: www.musili.fi/smtr/english. Accessed March 6, 2008.
23. Klaukka T, Kaarela K. Methotrexate is the leading DMARD in Finland. Ann Rheum Dis 2003;62:494-6.
24. Kaipiainen-Seppanen O, Aho K, Isomäki H, Laakso M. Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990. Clin Exp Rheumatol 1996;14:537-42.
25. Hazenberg BPC, van Rijswijk MH. Where has secondary amyloidosis gone? Ann Rheum Dis 2000;59:577-9.
26. Immonen K, Helin H, Lehtinen K, Hakala M. The usefulness of subcutaneous fat tissue aspiration biopsy for early confirmation of amyloidosis in patients with active ankylosing spondylitis: comment on the article by van Gameron et al. Arthritis Rheum 2007;56:2467.